Emil Freireich

Emil Freireich

UNVERIFIED PROFILE

Are you Emil Freireich?   Register this Author

Register author
Emil Freireich

Emil Freireich

Publications by authors named "Emil Freireich"

Are you Emil Freireich?   Register this Author

67Publications

1036Reads

46Profile Views

Toward the potential cure of leukemias in the next decade.

Cancer 2018 11 6;124(22):4301-4313. Epub 2018 Oct 6.

Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/cncr.31669
Publisher Site
http://dx.doi.org/10.1002/cncr.31669DOI Listing
November 2018

Proceedings of the Third Annual Meeting of the Society of Hematologic Oncology.

Clin Lymphoma Myeloma Leuk 2016 08;16 Suppl:S1

The University of Texas MD Anderson Cancer Center.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clml.2016.07.001DOI Listing
August 2016

Commentary on Thomas and Epstein: "Bone Marrow Transplantation in Acute Leukemia".

Authors:
Emil Freireich

Cancer Res 2016 Mar;76(6):1301-2

University of Texas MD Anderson Cancer Center, Houston, Texas.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-16-0366DOI Listing
March 2016

In Support of a Patient-Driven Initiative and Petition to Lower the High Price of Cancer Drugs.

Authors:
Ayalew Tefferi Hagop Kantarjian S Vincent Rajkumar Lawrence H Baker Jan L Abkowitz John W Adamson Ranjana Hira Advani James Allison Karen H Antman Robert C Bast John M Bennett Edward J Benz Nancy Berliner Joseph Bertino Ravi Bhatia Smita Bhatia Deepa Bhojwani Charles D Blanke Clara D Bloomfield Linda Bosserman Hal E Broxmeyer John C Byrd Fernando Cabanillas George Peter Canellos Bruce A Chabner Asher Chanan-Khan Bruce Cheson Bayard Clarkson Susan L Cohn Gerardo Colon-Otero Jorge Cortes Steven Coutre Massimo Cristofanilli Walter J Curran George Q Daley Daniel J DeAngelo H Joachim Deeg Lawrence H Einhorn Harry P Erba Francisco J Esteva Elihu Estey Isaiah J Fidler James Foran Stephen Forman Emil Freireich Charles Fuchs James N George Morie A Gertz Sergio Giralt Harvey Golomb Peter Greenberg Jordan Gutterman Robert I Handin Samuel Hellman Paulo Marcelo Hoff Ronald Hoffman Waun Ki Hong Mary Horowitz Gabriel N Hortobagyi Clifford Hudis Jean Pierre Issa Bruce Evan Johnson Philip W Kantoff Kenneth Kaushansky David Khayat Fadlo R Khuri Thomas J Kipps Margaret Kripke Robert A Kyle Richard A Larson Theodore S Lawrence Ross Levine Michael P Link Scott M Lippman Sagar Lonial Gary H Lyman Maurie Markman John Mendelsohn Neal J Meropol Yoav Messinger Therese M Mulvey Susan O'Brien Roman Perez-Soler Raphael Pollock Josef Prchal Oliver Press Jerald Radich Kanti Rai Saul A Rosenberg Jacob M Rowe Hope Rugo Carolyn D Runowicz Brenda M Sandmaier Alan Saven Andrew I Schafer Charles Schiffer Mikkael A Sekeres Richard T Silver Lillian L Siu David P Steensma F Marc Stewart Wendy Stock Richard Stone Rainer Storb Louise C Strong Martin S Tallman Michael Thompson Naoto T Ueno Richard A Van Etten Julie M Vose Peter H Wiernik Eric P Winer Anas Younes Andrew D Zelenetz Charles A LeMaistre

Mayo Clin Proc 2015 Aug 23;90(8):996-1000. Epub 2015 Jul 23.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.mayocp.2015.06.001DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5365030PMC
August 2015

Granulocyte concentrates from a single high-yield apheresis can be split to support multiple patients.

Leuk Lymphoma 2014 Nov 24;55(11):2577-83. Epub 2014 Feb 24.

Department of Laboratory Medicine, The University of Texas M. D. Anderson Cancer Center , Houston, TX , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3109/10428194.2014.883619DOI Listing
November 2014

The leukemias: a half-century of discovery.

J Clin Oncol 2014 Nov 2;32(31):3463-9. Epub 2014 Sep 2.

Dana-Farber Cancer Institute, Boston, MA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2014.57.1034DOI Listing
November 2014

The proceedings of the initial meeting of the Society of Hematologic Oncology 2013.

Clin Lymphoma Myeloma Leuk 2014 Sep;14 Suppl:S1

Professor of Medicine & Internist, Department of Leukemia, The University of Texas MD Anderson Cancer Center, Co-Founder & Director, Society of Hematologic Oncology.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clml.2014.08.001DOI Listing
September 2014

Emil Frei III, 1924-2013.

J Clin Oncol 2013 Oct 9;31(30):3727-30. Epub 2013 Sep 9.

Mount Sinai School of Medicine, New York, NY.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2013.51.8126DOI Listing
October 2013

Retrospect of hematological malignancies 2012.

Clin Lymphoma Myeloma Leuk 2013 Sep;13 Suppl 2:S271

Ruth Harriet Ainsworth Chair, Distinguished Teaching Professor, Director, Adult Leukemia Research Program, Director, Office of Graduate Medical Education, The University of Texas MD Anderson Cancer Center, Founding President & Director, Society of Hematologic Oncology.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clml.2013.08.001DOI Listing
September 2013

The Society of Hematologic Oncology (SOHO): moving forward in the battle against hematologic malignancies.

Authors:
Emil J Freireich

Clin Lymphoma Myeloma Leuk 2012 Dec;12(6):385

Society of Hematologic Oncology, Leukemia Department, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clml.2012.10.001DOI Listing
December 2012

The history of leukemia therapy--a personal journey.

Authors:
Emil J Freireich

Clin Lymphoma Myeloma Leuk 2012 Dec;12(6):386-92

University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clml.2012.09.014DOI Listing
December 2012

Clinical and proteomic characterization of acute myeloid leukemia with mutated RAS.

Cancer 2012 Nov 8;118(22):5550-9. Epub 2012 May 8.

Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.27596DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3416961PMC
November 2012

Leukocyte transfusion and the development of the continuous-flow blood cell separator.

Authors:
Emil J Freireich

Transfus Med Rev 2011 Oct 31;25(4):344-50. Epub 2011 May 31.

The University of Texas M.D. Anderson Cancer Center, 1515 Holcombe Boulevard, Unit 55, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.tmrv.2011.04.004DOI Listing
October 2011

Origins of platelet transfusion therapy.

Authors:
Emil J Freireich

Transfus Med Rev 2011 Jul 2;25(3):252-6. Epub 2011 Mar 2.

The University of Texas M.D. Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.tmrv.2011.01.003DOI Listing
July 2011

Twenty-five years of peripheral blood stem cell transplantation.

Blood 2011 Jun 1;117(24):6411-6. Epub 2011 Apr 1.

Department of Stem Cell Transplantation and Cellular Therapy, University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Blvd., Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2010-12-322214DOI Listing
June 2011

The 6-MP versus placebo clinical trial in acute leukemia.

Clin Trials 2011 Jun;8(3):288-97

Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, DC, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1740774511407358DOI Listing
June 2011

Retrospect of hematologic malignancies 2010.

Clin Lymphoma Myeloma Leuk 2011 Jun 23;11 Suppl 1:S1. Epub 2011 May 23.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clml.2011.05.038DOI Listing
June 2011

MER1, a novel organic arsenic derivative, has potent PML-RARalpha-independent cytotoxic activity against leukemia cells.

Invest New Drugs 2010 Aug 26;28(4):402-12. Epub 2009 May 26.

Department of Leukemia, The University of Texas M. D. Anderson Cancer Center, Unit 428, 1515 Holcombe Blvd., Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10637-009-9267-zDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4378574PMC
August 2010

Late relapses in acute myeloid leukemia: analysis of characteristics and outcome.

Leuk Lymphoma 2010 May;51(5):778-82

Department of Leukemia, The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Boulevard, Unit 428, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3109/10428191003661852DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4086357PMC
May 2010

Leukemia research, 2008.

Clin Lymphoma Myeloma 2009 ;9 Suppl 3:S178

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3816/CLM.2009.s.008DOI Listing
January 2010

Other malignancies in chronic lymphocytic leukemia/small lymphocytic lymphoma.

J Clin Oncol 2009 Feb 29;27(6):904-10. Epub 2008 Dec 29.

Department of Leukemia, The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Blvd, Unit 455, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2008.17.5398DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4979239PMC
February 2009

The role of investigational therapy in management of patients with advanced metastatic malignancy.

J Clin Oncol 2009 Jan 8;27(2):304-6. Epub 2008 Dec 8.

Special Medical Education Programs, The University of Texas M D Anderson Cancer Center, 1515 Holcombe Blvd, Unit 55, Houston, TX 77030, SUA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2008.19.6543DOI Listing
January 2009

Chemical and clinical development of darinaparsin, a novel organic arsenic derivative.

Anticancer Agents Med Chem 2008 Dec;8(8):904-9

Department of Chemistry, Texas A&M University, College Station, TX 77842-3012, USA.

View Article

Download full-text PDF

Source
December 2008

Should terminally ill patients have the right to take drugs that pass phase I testing? Yes.

Authors:
Emil J Freireich

BMJ 2007 Sep;335(7618):478

Special Medical Education Programs, University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/bmj.39244.451192.ADDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1971171PMC
September 2007

Arsenic derivatives in hematologic malignancies: a role beyond acute promyelocytic leukemia?

Hematol Oncol 2006 Dec;24(4):181-8

Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX 77230-1402, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/hon.787DOI Listing
December 2006

Influence of high-efficiency particulate air filtration on mortality and fungal infection: a rebuttal.

J Infect Dis 2006 Dec;194(11):1621-2; author reply 1622-3

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1086/508784DOI Listing
December 2006

Phase II study of low-dose interleukin-11 in patients with myelodysplastic syndrome.

Leuk Lymphoma 2006 Oct;47(10):2049-54

Hematology-Oncology Division, Hollings Cancer Center, Medical University of South Carolina, Charleston, South Carolina, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/10428190600758058DOI Listing
October 2006

Randomization in Phase II Clinical Trials.

Clin Adv Hematol Oncol 2006 Oct;4(10):776-8

NSABP Biostatistical Center, Pittsburgh, PA, USA.

View Article

Download full-text PDF

Source
October 2006

The investigational new drug application--who benefits?

Authors:
Emil J Freireich

Nat Clin Pract Oncol 2006 Feb;3(2):62-3

Special Medical Education Programs, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://www.nature.com/doifinder/10.1038/ncponc0429
Publisher Site
http://dx.doi.org/10.1038/ncponc0429DOI Listing
February 2006

Metastasis--an alternative hypothesis.

Cancer 2005 Apr;103(8):1537-9

Department of Leukemia, The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.20935DOI Listing
April 2005

Impact of high-dose granulocyte transfusions in patients with cancer with candidemia: retrospective case-control analysis of 491 episodes of Candida species bloodstream infections.

Cancer 2004 Dec;101(12):2859-65

Department of Infectious Diseases, Infection Control, and Employee Health, The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.20710DOI Listing
December 2004

Relative increase in leukemia-specific DNA in peripheral blood plasma from patients with acute myeloid leukemia and myelodysplasia.

Blood 2004 Apr 23;103(7):2799-801. Epub 2003 Oct 23.

Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2003-06-1840DOI Listing
April 2004

Troxacitabine and imatinib mesylate combination therapy of chronic myeloid leukaemia: preclinical evaluation.

Br J Haematol 2004 Mar;124(6):727-38

Department of Leukemia, M.D. Anderson Cancer Center, The University of Texas, Houston 77030-4009, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1365-2141.2004.04831.xDOI Listing
March 2004

Dexrazoxane's protection of jejunal crypt cells in the jejunum of C3Hf/Kam mice from doxorubicin-induced toxicity.

Cancer Chemother Pharmacol 2003 Dec 21;52(6):477-81. Epub 2003 Jun 21.

Departments of Leukemia and Special Medical Educations Program-Unit 55, The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00280-003-0655-3DOI Listing
December 2003

Dexrazoxane in combination with anthracyclines lead to a synergistic cytotoxic response in acute myelogenous leukemia cell lines.

Leuk Res 2003 Jul;27(7):617-26

Departments of Leukemia and Special Medical Education Programs, M.D. Anderson Cancer Center, Unit 55, The University of Texas, 1515 Holcombe Boulevard, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/s0145-2126(02)00273-4DOI Listing
July 2003

Sudden onset of the blastic phase of chronic myelogenous leukemia: patterns and implications.

Cancer 2003 Jul;98(1):81-5

Department of Leukemia, The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.11477DOI Listing
July 2003

Bone marrow purging studies in acute myelogenous leukemia using the recombinant anti-CD33 immunotoxin HuM195/rGel.

Biol Blood Marrow Transplant 2003 Jun;9(6):364-72

Department of Special Medical Education Programs and Adult Leukemia Research Program, M.D. Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
June 2003

In vitro activity of dimethylarsinic acid against human leukemia and multiple myeloma cell lines.

Cancer Chemother Pharmacol 2003 May 26;51(5):427-32. Epub 2003 Mar 26.

Department of Special Medical Education Programs, The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00280-003-0588-xDOI Listing
May 2003

Differences in CD33 intensity between various myeloid neoplasms.

Am J Clin Pathol 2002 Oct;118(4):560-6

Department of Hematopathology, University of Texas M.D. Anderson Cancer Center, Houston 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1309/1WMW-CMXX-4WN4-T55UDOI Listing
October 2002

Min Chiu Li: a perspective in cancer therapy.

Authors:
Emil J Freireich

Clin Cancer Res 2002 Sep;8(9):2764-5

Adult Leukemia Research Program, Special Medical Education Programs, The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030, USA.

View Article

Download full-text PDF

Source
September 2002

Myelodysplastic syndrome is not merely "preleukemia".

Blood 2002 Aug;100(3):791-8

Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston 77030-4095, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood.v100.3.791DOI Listing
August 2002

Effective cytotoxicity against human leukemias and chemotherapy-resistant leukemia cell lines by N-N-dimethylsphingosine.

Leuk Res 2002 Mar;26(3):301-10

Departments of Special Medical Education Programs, Molecular and Cellular Oncology and Genitourinary Medical Oncology, Division of Medicine, The University of Texas M.D. Anderson Cancer Center, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/s0145-2126(01)00129-1DOI Listing
March 2002